Search results
Millions of Americans may get their Medicare Advantage benefits cut
Newsweek· 18 hours agoMillions of Americans on Humana's Medicare Advantage plans could see their health care benefits cut...
Best Medicare Advantage Plans in Maryland 2024 - NerdWallet
Nerdwallet· 3 days agoThere are several companies selling Medicare Advantage plans in Maryland. See which ones have plans...
CVS’s stock suffers biggest drop in 15 years as Medicare Advantage issues weigh on results
Market Watch· 1 day agoCVS was also feeling “the unfavorable impact” of the drop in itsMedicare Advantage star rating,...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 4 hours agoLilly plans to file for regulatory approvals this year for tirzepatide in treating obstructive sleep apnea, which should open up the big Medicare market....
Care N’ Care Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 3 days agoCare N' Care Medicare Advantage plans are available in Texas and get below-average star ratings from...
Denmark, home of Ozempic, feels the drug's effects
Semafor via Yahoo Finance· 19 hours agoMeanwhile, the US Federal Trade Commission has argued that Novo Nordisk is using patents to keep prices high, and the Senate has launched an...
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 3 hours agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...
... Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug,...
Sierra Sun Times· 7 days agoIn a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of...
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? - What’s News - WSJ Podcasts
The Wall Street Journal· 4 hours agoEmily Field: This morning, Novo talked about a quadrupling of new patients starting Wegovy on a weekly basis in the United States. Luke Vargas: Plus, Exxon Mobil reaches an agreement to close ...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 18 hours ago"The maximum fair...also note that Eliquis faces generic competition in several international...
